| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/27/2011 | US20110021604 Methods and compositions for the specific inhibition of kras by asymmetric double-stranded rna |
| 01/27/2011 | US20110021600 Novel nucleic acid |
| 01/27/2011 | US20110021577 Aryloxy amine compounds and their use as sodium channel modulators |
| 01/27/2011 | US20110021574 Anti-cancer compounds, synthesis thereof, and methods of using same |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021483 Platinum (IV) Complexes |
| 01/27/2011 | US20110021466 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 01/27/2011 | US20110021445 Compositions and methods for treating erectile dysfunction |
| 01/27/2011 | US20110021444 Compositions for controlling hair growth |
| 01/27/2011 | US20110021440 Apoptotic pathway targeting for the diagnosis and treatment of cancer |
| 01/27/2011 | US20110021430 Modified vitamin k-dependent polypeptides |
| 01/27/2011 | US20110021429 Renoprotection by growth hormone-releasing hormone and agonists |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110021412 Human Receptor Proteins; Related Reagents and Methods |
| 01/27/2011 | US20110021373 Antibody categorization based on binding characteristics |
| 01/27/2011 | US20110021369 Single cell based reporter assay to monitor gene expression patterns with high spatio-temporal resolution |
| 01/27/2011 | US20110020933 Method and device for receiving biological cells from a stem cell culture |
| 01/27/2011 | US20110020932 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 01/27/2011 | US20110020931 Proliferation promoting agent for neural stem cells |
| 01/27/2011 | US20110020930 Enrichment of Stem Cells from Adult Tissues |
| 01/27/2011 | US20110020929 Partially active microfluidic system for 3d cell cultivation and method for perfusion thereof |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020927 Method Of Transfecting Cells With Nucleic Acids Using Acidified Polyethylenimine |
| 01/27/2011 | US20110020907 Viruses lacking epithelial cell receptor entry |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020899 Glucoamylase variants with altered properties |
| 01/27/2011 | US20110020896 Mutant dna polymerases and their genes |
| 01/27/2011 | US20110020870 Methods for producing modified glycoproteins |
| 01/27/2011 | US20110020843 Label-free methods related to phosphodiesterases |
| 01/27/2011 | US20110020816 Precursor miRNA loop-modulated target regulation |
| 01/27/2011 | US20110020814 Methods and compositions for selection of stem cells |
| 01/27/2011 | US20110020811 involving overexpression of alpha 1,2 mannosidase (MAN1C1) activity to improve protein production; improved glycoprotein production |
| 01/27/2011 | US20110020810 Trpc6 involved in glomerulonephritis |
| 01/27/2011 | US20110020807 Methylated CpG Island Amplification (MCA) |
| 01/27/2011 | US20110020802 Nucleic acids, methods and kits for the diagnosis of dyt6 primary torsion dystonia |
| 01/27/2011 | US20110020798 Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 01/27/2011 | US20110020790 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 01/27/2011 | US20110020433 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 01/27/2011 | US20110020398 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 01/27/2011 | US20110020396 HIV Envelope-CD4 Complexes and Hybrids |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020372 Follistatin domain containing proteins |
| 01/27/2011 | US20110020371 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery |
| 01/27/2011 | US20110020369 Engineered anti-tslpr antibodies |
| 01/27/2011 | US20110020363 Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13ralpha1) |
| 01/27/2011 | US20110020361 Human anti-mesothelin monoclonal antibodies |
| 01/27/2011 | US20110020360 Targeted binding agents directed to pdgrf-alpha and uses thereof |
| 01/27/2011 | US20110020355 Treatment and prevention of gardnerella vaginalis infections |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020353 Antibodies and related molecules that bind to 161p2f10b proteins |
| 01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 01/27/2011 | US20110020349 Anti-factor xi monoclonal antibodies and methods of use thereof |
| 01/27/2011 | US20110020347 Anti-brak (cxcl14) human monoclonal antibody and use thereof |
| 01/27/2011 | US20110020345 Drug fusions and conjugates |
| 01/27/2011 | US20110020344 Human monoclonal antibodies specific for cd22 |
| 01/27/2011 | US20110020343 Auristatin drug linker conjugates |
| 01/27/2011 | US20110020342 Igf-1 fusion polypeptides and therapeutic uses thereof |
| 01/27/2011 | US20110020330 Antibody inhibitors of gdf-8 and uses thereof |
| 01/27/2011 | US20110020329 Conjugates of anti-rg-1 antibodies |
| 01/27/2011 | US20110020323 Gram-positive bacteria specific binding compounds |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020314 Identifying haematopoietic stem cells based on cell surface markers |
| 01/27/2011 | US20110020309 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergice disease |
| 01/27/2011 | US20110020308 Expression of transgenic t cell receptors in lak-t cells |
| 01/27/2011 | US20110020300 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/27/2011 | US20110020299 Method and composition for the regeneration of tissue with the aid of stem cells or bone marrow cells |
| 01/27/2011 | US20110020297 Dner-mediated cell purification of pancreatic endocrine pre-progenitor cells and their progeny |
| 01/27/2011 | US20110020296 Methods for treating diseases and increasing longevity |
| 01/27/2011 | US20110020293 Use of Stem Cells to Reduce Leukocyte Extravasation |
| 01/27/2011 | US20110020291 Use of stem cells for wound healing |
| 01/27/2011 | US20110020282 Recombinant newcastle disease virus |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020239 Methods for in vivo imaging of cells |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020223 Polypeptides having affinity for her2 |
| 01/27/2011 | US20110020220 Humanized antibodies against the beta-amyloid peptide |
| 01/27/2011 | US20110020219 Anti-human tenascin monoclonal antibody |
| 01/27/2011 | US20110020218 Novel anti cxcr4 antibodies and their use for the treatment of cancer |
| 01/27/2011 | US20110017733 Kit for collecting blood, preferably peripheral blood, for the production of stem cells |
| 01/27/2011 | CA2768807A1 Cell-mediated silica sol-gel encapsulation of living cells and tissues |
| 01/27/2011 | CA2768720A1 Differentiation of human embryonic stem cells |
| 01/27/2011 | CA2768644A1 Differentiation of human embryonic stem cells |
| 01/27/2011 | CA2768643A1 Differentiation of human embryonic stem cells |
| 01/27/2011 | CA2768613A1 Methods and compositions for improving the viability of cryopreserved cells |
| 01/27/2011 | CA2768576A1 Use of stem cells to reduce leukocyte extravasation |
| 01/27/2011 | CA2768573A1 Use of stem cells to reduce leukocyte extravasation |
| 01/27/2011 | CA2768562A1 Enzymatic composition for the digestion of chicken embryos |
| 01/27/2011 | CA2768502A1 Sugarcane centromere sequences and minichromosomes |
| 01/27/2011 | CA2768125A1 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods |
| 01/27/2011 | CA2767929A1 Method for obtaining myofibroblasts |
| 01/27/2011 | CA2767724A1 Sorghum centromere sequences and minichromosomes |
| 01/27/2011 | CA2767377A1 Method for genome editing |
| 01/27/2011 | CA2708848A1 Method for preparing porous collagen matrices |